Major companies in the market are focused on various business strategies such as gaining product approval from regulatory authorities, in order gain competitive edge in the market. For instance, in February 2018, Becton, Dickson and Company received CE-IVD marking for its PAXgene Blood ccfDNA tube, which is commercially available in Western Europe.
Key players in the market are focused on various business strategies such as product launches, in order to expand their product portfolio and enhance the market presence. For instance, in February 2019, Greiner Bio-One, an Austria-based biotechnology device manufacturer, launched the new VACUETTE SAFELINK Holder. This is a sterile tube holder, which provides a safe, needless option for blood collection.
Key companies in the market are involved in various business strategies such as product launches, in order to expand their product portfolio and gain competitive edge in the market. For instance, Greiner Bio-One launched MiniCollect K2EDTA Capillary Collection Tube. These capillary tubes are designed to collect and transport blood samples with sterile environment.